Works by Li, Shengmei


Results: 22
    1

    Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor–Positive Human Epidermal Growth Factor Receptor-2–Negative Early Breast Cancer Without Chemotherapy.

    Published in:
    JAMA Network Open, 2022, v. 5, n. 2, p. e2145934, doi. 10.1001/jamanetworkopen.2021.45934
    By:
    • Fu, Fangmeng;
    • Yu, Liuwen;
    • Zeng, Bangwei;
    • Chen, Minyan;
    • Guo, Wenhui;
    • Chen, Lili;
    • Lin, Yuxiang;
    • Hou, Jialin;
    • Li, Jing;
    • Li, Yan;
    • Li, Shengmei;
    • Chen, Xiaobin;
    • Zhang, Wenzhe;
    • Jin, Xuan;
    • Cai, Weifeng;
    • Zhang, Kun;
    • Chen, Hanxi;
    • Qiu, Yibin;
    • Nie, Qian;
    • Wang, Chuan
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    Cardiovascular Events Associated with CDK4/6 Inhibitors: A Safety Meta-Analysis of Randomized Controlled Trials and a Pharmacovigilance Study of the FAERS Database.

    Published in:
    American Journal of Cardiovascular Drugs, 2025, v. 25, n. 3, p. 373, doi. 10.1007/s40256-024-00709-6
    By:
    • Zhang, Chengrong;
    • Shen, Guoshuang;
    • Li, Shengmei;
    • Ma, Fei;
    • Li, Huihui;
    • Tang, Yuyao;
    • Li, YongXin;
    • Li, Zhoujuan;
    • Zhu, Zijun;
    • Qiu, Tianlei;
    • Liu, Zhilin;
    • Zhao, Yi;
    • Huang, Shifeng;
    • Zhao, Fuxing;
    • Kong, Fanzhen;
    • Zhao, Jiuda
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22